Legal Opinion

Vanda Pharmaceuticals, Inc. v. FDA

Court of Appeals for the D.C. Circuit

Decided August 18, 2026No. 25-5041Published

1Opinion of the Court

United States Court of Appeals FOR THE DISTRICT OF COLUMBIA CIRCUIT Argued March 12, 2026 Decided August 18, 2026 No. 25-5041 VANDA PHARMACEUTICALS, INC., APPELLANT v. UNITED STATES FOOD AND DRUG ADMINISTRATION, ET AL., APPELLEES Appeal from the United States District Court for the District of Columbia (No. 1:23-cv-00280) Paul W. Hughes III argued the cause for appellant. With him on the briefs were Sarah Hogarth and Connor Suozzo. David L. Peters, Attorney, U.S. Department of Justice, argued the cause for defendants-appellees. With him on the brief were Brett A. Shumate, Assistant Attorney…

2Cases cited29 opinions

  1. Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
  2. Motor Vehicle Mfrs. Assn. of United States, Inc. v. State Farm Mut. Automobile Ins. Co.Supreme Court of the United States · 1983
  3. Abbott Laboratories v. GardnerSupreme Court of the United States · 1967
  4. Skidmore v. Swift & Co.Supreme Court of the United States · 1944
  5. Food & Drug Administration v. Brown & Williamson Tobacco Corp.Supreme Court of the United States · 2000

24 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API